(17315310), C. G., (17315313), M. Z., (17315316), G. C. M., (17315319), J. V. V., (15052230), J. F. F., (17315322), S. P., . . . (17315340), T. C. T. (2025). Supplementary Figure S18 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression.
Chicago-viite (17. p.)(17315310), Chuandong Geng, et al. Supplementary Figure S18 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression. 2025.
MLA-viite (9. p.)(17315310), Chuandong Geng, et al. Supplementary Figure S18 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression. 2025.